Hemispherian AS
PrivateLast Round
Joint Venture
Sep 29, 2025
Total Funding Raised
$10.01M
Momentum Score
75 /100
Company Overview
Hemispherian AS is a clinical-stage pharmaceutical company developing a novel class of small molecule drugs (GLIX) that target the TET2 enzyme to treat aggressive cancers like glioblastoma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemispherian AS Comps
Public and private peers based on sector, stage, and business model.
Hemispherian AS Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Joint Venture | Sep 29, 2025 | ||||
| Grant | Dec 19, 2023 | ||||
| Series A | Nov 24, 2022 | ||||
| Grant | Oct 19, 2022 | ||||
| VC Round | Oct 19, 2022 | ||||
Seed | May 3, 2022 |
Key People
Founding team and executive leadership
Hemispherian AS Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Grant |
| European Commission | Grant |
| Kistefos | Series A |
| Investinor | Seed |
| Meneldor | Seed, Series A |
| Kvantia | Series A |
| The Research Council of Norway | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 343% MoM.
- Sep 29, 2025
Completed a joint venture funding round.
Hemispherian AS Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemispherian AS's valuation, stock price, and market status.
